| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/10/2010 | US20100144798 Modulators of ATP-Binding Cassette Transporters |
| 06/10/2010 | US20100144786 Quinoline derivatives as crth2 receptor ligands |
| 06/10/2010 | US20100144780 salts of N-acridonacetic acid such as N-(1-deoxy-D-glucitol-1-yl)-N-ethyl ammonium 9-oxoacridine-10-ylacetate, having immunomodulating, antiparasitic, antisclerotic, antiviral, antibacterial, antifungal, antiphlogistic, antitumor, radioprotective and stressprotective activities |
| 06/10/2010 | US20100144750 Use of N-Phenyl-2-Pyrimidineamine Derivatives Against Mast Cell-Based Diseases Like Allergic Disorders |
| 06/10/2010 | US20100144736 Novel biphenyl thio-urea derivatives useful as potassium channel modulators |
| 06/10/2010 | US20100144721 Inhibitors of c-met and uses thereof |
| 06/10/2010 | US20100144661 Sodium channel blockers |
| 06/10/2010 | US20100144653 Fatty acid carbohydrate hybrid molecules as therapeutic agents and methods thereof |
| 06/10/2010 | US20100144630 Compositions, methods and uses for inhibition and/or treatment of influenza infection |
| 06/10/2010 | US20100144615 Nucleotide sequence encoding a modulator of nf-kb |
| 06/10/2010 | US20100144611 Treatment of t-cell mediated diseases |
| 06/10/2010 | US20100144599 Vegf pathway blockade |
| 06/10/2010 | US20100143471 Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine |
| 06/10/2010 | US20100143456 Model membrane systems |
| 06/10/2010 | US20100143454 Flavivirus NS5A Proteins For the Treatment of HIV |
| 06/10/2010 | US20100143440 Ul97 inhibitors for treatment of proliferative disorders |
| 06/10/2010 | US20100143417 Compositions and methods for controlling diseases in animals |
| 06/10/2010 | US20100143405 Immunotherapy of virus infection |
| 06/10/2010 | US20100143404 Thiophene derivatives for up-regulating HLA-DM activity |
| 06/10/2010 | US20100143402 Intergenic sites between conserved genes in the genome of modified vaccinia ankara (mva) vaccinia virus |
| 06/10/2010 | US20100143401 Vaccine preventing and/or treating autoimmune diseases |
| 06/10/2010 | US20100143394 Synthetic streptococcus pneumoniae vaccine |
| 06/10/2010 | US20100143392 Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof |
| 06/10/2010 | US20100143390 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 06/10/2010 | US20100143370 Set of means for treating a malignant pathology, an autoimmune disease or an infectious disease |
| 06/10/2010 | US20100143369 Interferon Alpha Receptor I Antibodies And Their Use |
| 06/10/2010 | US20100143368 Human Antibodies That Bind Cd22 And Uses Thereof |
| 06/10/2010 | US20100143353 POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (lgG) AND METHODS OF USING THE SAME |
| 06/10/2010 | US20100143352 Combination therapy for b cell disorders |
| 06/10/2010 | US20100143347 Targeting ncca-atp channel for organ protection following ischemic episode |
| 06/10/2010 | US20100143338 Treatment of t-cell mediated diseases |
| 06/10/2010 | US20100143336 Toll-like receptor binding epitope and compositions for binding thereto |
| 06/10/2010 | US20100143334 T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation |
| 06/10/2010 | US20100143329 Reimmunization and antibody design |
| 06/10/2010 | US20100143328 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
| 06/10/2010 | US20100143323 Modified phosphatases |
| 06/10/2010 | US20100143314 In Vivo Production and Delivery of Erythropoietin or Insulinotropin for Gene Therapy |
| 06/10/2010 | US20100143312 Treatment of diseases, disorders or conditions of the lung using placental cells |
| 06/10/2010 | US20100143303 Composition comprising lactic acid bacterium having high anti-allergic activity, and method for production of the lactic acid bacterium |
| 06/10/2010 | US20100143302 Recombinant Adenoviruses Based on Serotype 26 and 48, and Use Thereof |
| 06/10/2010 | US20100143296 Podophyllotoxin inhibitors of topoisomerase ii |
| 06/10/2010 | US20100143293 T cell activation |
| 06/10/2010 | US20100143269 Pharmaceutical compositions for the treatment of asthma |
| 06/10/2010 | US20100143262 Method for Identifying Allergenic Proteins And Peptides |
| 06/10/2010 | US20100143246 Interleukin 17 Receptor-Like Protein |
| 06/10/2010 | CA2745356A1 2h-chromene compound and derivative thereof |
| 06/10/2010 | CA2745041A1 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer |
| 06/10/2010 | CA2744960A1 Il-3 inhibitors in use for treatment of rheumatoid arthritis in an early stage |
| 06/10/2010 | CA2744507A1 Pyrrolopyrazinyl urea kinase inhibitors |
| 06/09/2010 | EP2194066A1 Modified antibody constant region |
| 06/09/2010 | EP2193805A1 Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same |
| 06/09/2010 | EP2193790A1 IL-3 Inhibitors in use for treatment of rheumatoid arthritis in an early stage |
| 06/09/2010 | EP2193788A1 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 06/09/2010 | EP2193127A1 Benzothiazole compounds |
| 06/09/2010 | EP2193126A1 Oxadiazole diaryl compounds |
| 06/09/2010 | EP2193125A2 Oxadiazole derivatives |
| 06/09/2010 | EP2192915A1 Therapeutic uses of peptides ysaypdsvpmms and wmnstgftkvcgappc |
| 06/09/2010 | EP2192900A2 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 06/09/2010 | EP1737490B1 Methods of treating atherosclerosis |
| 06/09/2010 | EP1558649B1 Peptid modulating caspase activation |
| 06/09/2010 | EP1497273B1 Hydroxamic acid derivatives |
| 06/09/2010 | EP1459727B1 Nonhuman model animal unresponsive to immunopotentiating synthetic compound |
| 06/09/2010 | EP1385864B1 Anti-VEGF-2 antibodies |
| 06/09/2010 | EP1011686B1 Modulation of human mast cell activation |
| 06/09/2010 | EP0951295B1 Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis |
| 06/09/2010 | CN1935010B Health food for intensifying body immunological competence and improving memory function, and its preparing method |
| 06/09/2010 | CN1882589B Novel heterocyclic compounds as HSP90-inhibitors |
| 06/09/2010 | CN1868485B Medicine composition and its application |
| 06/09/2010 | CN101730699A Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases |
| 06/09/2010 | CN101730677A Amine compound and pharmaceutical use thereof |
| 06/09/2010 | CN101730545A Compounds and methods for the treatment of renal disease |
| 06/09/2010 | CN101724667A Technology for extracting dendrobium polysaccharide by applying biology engineering enzyme technology and product thereof and application |
| 06/09/2010 | CN101724622A Method for preparing Lactobacillus casei microcapsule |
| 06/09/2010 | CN101724541A Chinese traditional medicine health-care wine for enhancing immunity and relieving physical fatigue and preparation method thereof |
| 06/09/2010 | CN101724539A Formula of health-care wine and preparation method thereof |
| 06/09/2010 | CN101724075A Remodeling and glycoconjugation of peptides |
| 06/09/2010 | CN101724071A Single domain antibodies against TNFRl and methods of use therefor |
| 06/09/2010 | CN101724019A Thymopeptide-5 active esters, medicinal composition containing same and application thereof |
| 06/09/2010 | CN101723948A C-6 modified indazolylpyrrolotriazines |
| 06/09/2010 | CN101721706A Medicine composition containing matrine class alkaloid, preparation method and pharmaceutical application |
| 06/09/2010 | CN101721703A Electronic homeopathic remedy desensitizing edible preparation and preparation method thereof |
| 06/09/2010 | CN101721677A Thymopentin oral microsphere preparation and preparation method thereof |
| 06/09/2010 | CN101721633A Chinese herbal medicament promoting growth of animals |
| 06/09/2010 | CN101721630A Six-ingredient traditional Chinese medicine preparation for cooling blood and resisting toxicity |
| 06/09/2010 | CN101721618A External Chinese medicinal health-care bag for dispelling filth and preventing and treating influenza |
| 06/09/2010 | CN101721613A Composition for enhancing constitution and preparation method thereof |
| 06/09/2010 | CN101721571A Chinese herbal medicine footherapy fragrant flower |
| 06/09/2010 | CN101721565A Health care bee product and preparation method thereof |
| 06/09/2010 | CN101721551A Thrombus-resisting life-prolonging health-care wine prepared by taking gynostemma pentaphylla as main raw material |
| 06/09/2010 | CN101721545A Anti-tumor Chinese medicinal composition and preparation method thereof |
| 06/09/2010 | CN101721540A Traditional Chinese medicine for treating anaphylactic purpura |
| 06/09/2010 | CN101721538A Health-care cigarette prepared from rhiizoma dioscoreae from Henan of China and chrysanthemum and used for reinforcing immunological function |
| 06/09/2010 | CN101721492A Fluorescent scanning quantitative determination method for non-fluorescent compound paeonolum |
| 06/09/2010 | CN101721461A High dispersion preparation of rabdosia rubescens total terpenoid extract |
| 06/09/2010 | CN101721458A Method for preparing human placenta tissue fluid |
| 06/09/2010 | CN101721452A New process for improving utilization ratio of lithospermum |
| 06/09/2010 | CN101721446A Method for preparing composite oligosaccharide granules |
| 06/09/2010 | CN101721442A Method for preparing ginseng soaked by rice vinegar |
| 06/09/2010 | CN101721436A Compound fermented aweto capsule and preparation method thereof |
| 06/09/2010 | CN101721435A Ganoderma lucidum spore and nano selenium compound and preparation method thereof |